| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/10/2009 | US20090229016 Cambium/xylem-preferred promoters and uses thereof |
| 09/10/2009 | US20090229015 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto |
| 09/10/2009 | US20090229014 Drought and High Salinity Stress Induced Rice Promoters |
| 09/10/2009 | US20090229011 Disease-resistant plants and method of constructing the same |
| 09/10/2009 | US20090229006 Herbicide resistant plants |
| 09/10/2009 | US20090228998 Induction of exon skipping in eukaryotic cells |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227780 siRNA targeting connexin 43 |
| 09/10/2009 | US20090227774 Polyhedral Nanostructures Formed from Nucleic Acids |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227661 Transcription factor decoy oligodeoxynucleotides having multiple cis elements |
| 09/10/2009 | US20090227659 Nucleolar targeting of therapeutics against HIV |
| 09/10/2009 | US20090227657 Selective inhibition of pro-angiogenic VEGF pathway gene expression; Tissue targeted nanoparticle compositions comprising polymer (histidine-lysine copolymer) conjugates and nucleic acid molecules; antisense strand consists of the complement of SEQ ID NO: 286; ocular disease, arthritis, inflammation |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227509 Modulation of hiv replication by rna interference |
| 09/10/2009 | US20090227502 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227497 Variant activin receptor polypeptides and uses thereof |
| 09/10/2009 | US20090227473 Nucleic acid hybridization methods |
| 09/10/2009 | US20090227464 Prognosis determination in ewing sarcoma patients by means of genetic profiling |
| 09/10/2009 | US20090227029 Process for Chromosomal Engineering Using a Novel Dna Repair System |
| 09/10/2009 | US20090227021 Purified mammalian ctla-8 antigens and related reagents |
| 09/10/2009 | US20090227017 Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereof |
| 09/10/2009 | US20090227016 Il-17 homologous polypeptides and therapeutic uses thereof |
| 09/10/2009 | US20090227015 hepatocellular carcinoma; osteopontin and alpha-fetoprotein |
| 09/10/2009 | US20090227014 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/10/2009 | US20090227013 Early Endosperm Promoter eep2 |
| 09/10/2009 | US20090227012 Nucleotide sequences coding modified immunoglobulin for use in prevention and treatment of cancer and/or inflammatory disease |
| 09/10/2009 | US20090227010 Carbonic anhydrase having increased stability under high temperature conditions |
| 09/10/2009 | US20090227009 Selective terminal tagging of nucleic acids |
| 09/10/2009 | US20090226992 Enhancement of Microbial Ethanol Production |
| 09/10/2009 | US20090226990 Methods for the economical production of biofuel from biomass |
| 09/10/2009 | US20090226984 L-cysteine producing bacterium and a method for producing l-cysteine |
| 09/10/2009 | US20090226976 Methods for dynamic vector assembly of dna cloning vector plasmids |
| 09/10/2009 | US20090226973 Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
| 09/10/2009 | US20090226969 Spider Silk Proteins and Methods for Producing Spider Silk Proteins |
| 09/10/2009 | US20090226967 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma |
| 09/10/2009 | US20090226964 Polymyxin Synthetase and Gene Cluster Thereof |
| 09/10/2009 | US20090226961 Mutant alpha-amylases |
| 09/10/2009 | US20090226932 Novel G Protein-Coupled Receptor |
| 09/10/2009 | US20090226929 Titinic ion channel, compositions and methods of use |
| 09/10/2009 | US20090226925 Methods for Detecting Circulating Tumor Cells |
| 09/10/2009 | US20090226924 Modified Oligonucleotides and Applications Thereof |
| 09/10/2009 | US20090226920 Mutation In The Regulatory Region Of GJB2 Mediates Neonatal Hearing Loss Within DFNB1 |
| 09/10/2009 | US20090226888 Diagnostic Primers And Method For Detecting Avian Influenza Virus Subtype H5 And H5N1 |
| 09/10/2009 | US20090226886 Primers and probes for the detection of hiv |
| 09/10/2009 | US20090226885 Nucleic Acid Sequences That Can Be Used As Primers And Probes In The Amplification And Detection Of Sars Coronavirus |
| 09/10/2009 | US20090226569 Variants of A Bacillus Strearothermophilus Alpha-Amylase And Uses Thereof |
| 09/10/2009 | US20090226564 Bacterial alpha-amylase variants |
| 09/10/2009 | US20090226552 Agents and methods for diagnosing osteoarthritis |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226486 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 09/10/2009 | US20090226479 Vaccines and their use |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226470 Compositions and methods related to mRNA translational enhancer elements |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226466 Therapeutic anti-her2 antibody fusion polypeptides |
| 09/10/2009 | US20090226463 Novel method of modulating bone-related activity |
| 09/10/2009 | US20090226462 use of polypeptide in a vaccine for protection of fish from Aeromomas |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/10/2009 | US20090226442 RON antibodies and uses thereof |
| 09/10/2009 | US20090226421 Recombinant monovalent antibodies and methods for production thereof |
| 09/10/2009 | US20090226416 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 09/10/2009 | US20090226413 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226410 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226409 Pharmaceutical Compositions Comprising Sods and Prolamine Based Peptide Fragments |
| 09/10/2009 | US20090226405 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CUPREDOXINS AND CpG RICH DNA |
| 09/10/2009 | US20090226370 GEP, a novel chondrogenic growth factor and target in cartilage disorders |
| 09/09/2009 | EP2097542A1 Influenza b virus detection method and kit therefor |
| 09/09/2009 | EP2097436A2 Heteropolynucleotide duplexes with purine-purine base pairing |
| 09/09/2009 | EP2097435A1 Therapeutic treatments based on administration of small rna fragments |
| 09/09/2009 | EP2097433A2 Oligonucleotide arrays |
| 09/09/2009 | EP2097427A1 Compounds and methods for synthesis and purification of oligonucleotides |
| 09/09/2009 | EP2097091A2 Conjugate of natriuretic peptide and antibody constant region |
| 09/09/2009 | EP2096909A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 09/09/2009 | EP1856280A4 Compositions, methods, and kits for selective amplification of nucleic acids |
| 09/09/2009 | EP1734979A4 Follicle stimulating hormone superagonists |
| 09/09/2009 | EP1578382B1 Botulinum neurotoxin b receptors and use thereof |
| 09/09/2009 | EP1575977B1 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 09/09/2009 | CN101529252A Aptamers directed to MUC1 |
| 09/09/2009 | CN101528763A Methods and substances for isolation and detection of small polynucleotides |
| 09/09/2009 | CN101525660A An instant sequencing methodology |
| 09/09/2009 | CN101525605A Araboxylan degrading enzyme |
| 09/09/2009 | CN100537763C Compounds for hydrolysing ribonucleic acids (RNAs) |
| 09/09/2009 | CN100537761C Trans-oligonucleotide, medicinal composition containing it and use thereof |
| 09/09/2009 | CN100537591C Method for purifying small fragment DNA in gel by grinding method and use thereof |
| 09/09/2009 | CN100537590C RNA extraction method, RNA extraction reagent, and method for analyzing biological materials |
| 09/08/2009 | US7586028 Maize variety PHR1R |
| 09/08/2009 | US7586027 Maize variety PHHMD |
| 09/08/2009 | US7586023 Protoporphyrinogen oxidase resistant; genetic engineering |
| 09/08/2009 | US7585970 Method of polynucleotide synthesis using modified support |
| 09/08/2009 | US7585969 MicroRNA and methods for inhibiting same |
| 09/08/2009 | US7585968 airway hyperresponsiveness, and/or pulmonary inflammation; respiratory system disorders; aerosol |
| 09/08/2009 | US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 09/08/2009 | US7585966 Directed against accessible regions in the telomerase ribonucleoprotein; cancer |
| 09/08/2009 | US7585965 Metallic object with a nucleic acid coating and derivatives thereof and method for producing said object |